| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Seres Therapeutics, Inc. (MCRB) has 9 insiders with recent SEC Form 4 filings, including 0 buys and 7 sells. MCRB is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 56.3K | $371.3K | - | |
| Other | 22.5K | $148.5K | - | |
| Dir | 11.5K | $75.7K | - | |
| Dir | 11.0K | $72.6K | - | |
| Dir | 10.0K | $66.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Apr 4, 2016 | Cook David N | Chief Scientific Officer &EVP | Sell | 61,000 | $26.16 | $1,595,586.00 | -10.4% | |
| Mar 31, 2016 | Shaff Eric D.66 | CFO And EVP | Sale+OE | 7,663 | $26.30 | $201,569.35 | -53.8% | |
| Mar 28, 2016 | Aunins John G. | Chief Technology Officer &EVP | Sell | 9,390 | $23.89 | $224,327.10 | -11.2% | |
| Mar 28, 2016 | Shaff Eric D.66 | CFO And EVP | Sale+OE | 5,473 | $24.07 | $131,735.11 | -100% |